LEUKEMIA, CHRONIC LYMPHATIC

Clinical trials for LEUKEMIA, CHRONIC LYMPHATIC explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, CHRONIC LYMPHATIC trials appear

Sign up with your email to follow new studies for LEUKEMIA, CHRONIC LYMPHATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Three-Pronged attack tested against Tough-to-Treat blood cancer

Disease control Completed

This study tested a combination of three medicines—ibrutinib, fludarabine, and pembrolizumab—for adults with a hard-to-treat form of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The goal was to see if using these drugs together could achieve a complete …

Matched conditions: LEUKEMIA, CHRONIC LYMPHATIC

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

LEUKEMIA, CHRONIC LYMPHATIC

Get alerted when new LEUKEMIA, CHRONIC LYMPHATIC trials appear

Three-Pronged attack tested against Tough-to-Treat blood cancer